SCHEMBL26371398

SCHEMBL26371398

N#CB1CCC(N)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetonitrile SCHEMBL29158023 0.69 — —
SCHEMBL22995951 0.69 — —
SCHEMBL23486409 0.67 — —
SCHEMBL24289456 0.67 — —
Water SCHEMBL736229 0.67 — —
SCHEMBL18461890 0.65 — —
Acetonitrile SCHEMBL29224147 0.65 — —
SCHEMBL24754156 0.64 ESR2 (0.32) —
SCHEMBL24890582 0.64 — —
Cyclohexylamine SCHEMBL28857860 0.63 THRB (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024073371-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
EP-3334710-B1 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISORDERS ALZHEON INC (US) 2023-10-04 — — EP disclosed
Send feedback